43 results
Page 2 of 3
8-K
EX-99.1
82bnovr
30 Jun 20
VistaGen Therapeutics Reports Fiscal Year 2020 Results and Provides CNS Pipeline Update
4:16pm
8-K
EX-99
tmosj2hcwkm ayjbq
1 Jun 20
VistaGen and Nuformix Announce Agreement to Develop Novel Patentable Cocrystalline Forms of AV-101 for Treatment of Multiple CNS Conditions
4:53pm
424B3
e1fsrrpnur4c75
15 May 20
Prospectus supplement
4:34pm
424B3
m1ferrj gy
15 Apr 20
Prospectus supplement
4:27pm
8-K
EX-99
jbb3ik9l 11b
13 Feb 20
VistaGen Therapeutics Reports Fiscal 2020 Third Quarter Financial Results and Provides CNS Pipeline Overview
4:39pm
8-K
EX-99
nmnq 1iwlgi2
13 Feb 20
VistaGen Therapeutics Reports Fiscal 2020 Third Quarter Financial Results and Provides CNS Pipeline Overview
4:39pm
8-K
EX-99.1
cakxw
26 Oct 18
Entry into a Material Definitive Agreement
4:21pm
8-K
EX-99.1
ull3rb3v4ccspk
14 Aug 18
Other Events
2:32pm
8-K
EX-99.1
jyu7bdgza6
3 May 18
VistaGen Therapeutics Receives Notice of Allowance for Japanese Patent regarding Methods of Production for AV-101
12:00am
8-K
EX-99.1
z24swm51cp7hp3be
6 Apr 18
VistaGen Therapeutics Initiates Phase 2 Study of AV-101 for Major Depressive Disorder
12:00am
424B4
6stx8k
28 Aug 14
Prospectus supplement with pricing info
12:00am